Important Zepbound Rule: Only the KwikPen® formulation of Zepbound is coverable under this program. Single-dose vials and single-dose pens are completely excluded.

An Important Note: The drug must be prescribed solely for chronic weight management (reducing excess body weight or maintaining weight reduction). If you have a diagnosis that allows standard Part D coverage for a GLP-1 (like Type 2 diabetes or a secondary covered indication), you must obtain the medication through your normal Part D plan instead.

Do I Qualify for the GLP-1 Bridge Program?

The Bridge program is entirely provider-driven, and eligibility is based on your physical metrics at the time you first initiated GLP-1 therapy (even if you started taking the medication before this program launches or before you enrolled in Medicare). 

• To be eligible: You must be at least 18 years old, actively enrolled in a standalone Medicare Prescription Drug Plan (PDP) or a Medicare Advantage plan with drug coverage (MA-PD), and meet one of the following baseline Body Mass Index (BMI) thresholds:

  • • BMI of 35 or greater: Automatically qualifies with no secondary medical conditions required.

    • BMI of 30 or greater: Requires a documented diagnosis of heart failure (including heart failure with preserved ejection fraction / HFpEF), uncontrolled hypertension (high blood pressure), or kidney disease.

    • BMI of 27 or greater: Requires a documented diagnosis of pre-diabetes (per American Diabetes Association guidelines), a previous heart attack (myocardial infarction), a previous stroke, or peripheral artery disease (PAD).

Disqualifying Conditions: 

Because the Bridge program is meant to fill an existing coverage gap, you are disqualified from using it if you have a diagnosis that allows standard Part D to cover a GLP-1. The primary disqualifying categories are:

Type 2 Diabetes Mellitus: Any form of Type 2 diabetes automatically routes your medication coverage through standard Part D. If you have Type 2 diabetes, you would typically be prescribed Mounjaro® (the identical tirzepatide molecule to Zepbound, but branded for diabetes) rather than Zepbound. Your standard Part D plan handles the authorization and cost-sharing according to your specific plan's formulary. 

Established Cardiovascular Disease (With Overweight or Obesity) 

Following updated CMS guidance, standard Part D plans cover certain weight-loss medications (specifically select brands of semaglutide like Wegovy®) if they are FDA-approved to reduce

major adverse cardiovascular events in individuals with established cardiovascular disease who are overweight or obese. 

If your medical history includes any of the following, a standard Part D plan can provide coverage under the core benefit rather than the Bridge program: 

• Prior Myocardial Infarction (Heart Attack): A documented history of a heart attack.
• Prior Stroke: A history of an ischemic or hemorrhagic stroke. 
• Established Peripheral Arterial Disease (PAD): Documented symptomatic blockages in the arteries of the limbs. The Overlap Catch: You might notice that a prior heart attack is listed as an eligible co-morbidity for the Bridge program if your BMI is 27 or greater. The critical detail is which drug is being used and what it is FDA-approved for. If a drug becomes FDA-approved to prevent heart attacks in people with obesity, standard Part D steps in to cover it, moving you out of the Bridge program. 

The Overlap Catch: You might notice that a prior heart attack is listed as an eligible co-morbidity for the Bridge program if your BMI is 27 or greater. The critical detail is which drug is being used and what it is FDA-approved for. If a drug becomes FDA-approved to prevent heart attacks in people with obesity, standard Part D steps in to cover it, moving you out of the Bridge program.

Out of Pocket cost for the GLP-1 Bridge Program:

If approved through the Bridge program, you will pay a flat $50 copay per monthly supply. 

The Cost Catch: Because this demonstration operates completely outside the normal Medicare Part D benefit framework, none of these costs count toward your Gross Covered Prescription Drug Costs (GCPDC) or your True Out-of-Pocket costs (TrOOP). The $50 copay remains identical regardless of what coverage phase your standard Part D plan is currently in. 

The Medicare GLP-1 Bridge program is specifically designed to cover anti-obesity medications used solely for chronic weight management. 

By law, standard Medicare Part D plans are prohibited from covering medications prescribed purely for weight loss. However, standard Part D plans are allowed to cover GLP-1 drugs if they are prescribed to treat other medically accepted indications. Because the Bridge program is meant to fill a coverage gap, having an indication that standard Part D can cover automatically disqualifies you from using the Bridge. 

If you are disqualified from the Bridge due to Type 2 diabetes or cardiovascular disease, your standard Part D costs will count toward your TrOOP cap. Once you hit that Part D out-of-pocket cap, your covered drugs cost $0 for the rest of the year. Money spent within the Bridge program offers no financial progress toward hitting that $0 threshold.

How to get started with Medicare's GLP-1 Bridge Program:

Beneficiaries do not need to register, submit applications, or enroll independently. The administrative onboarding is strictly handled between your doctor, a central processing entity, and your pharmacy. 

• Step 1: Initial Consultation. 

  Schedule an appointment with your doctor to review your medical history, baseline BMI metrics, and eligibility. As highlighted by the NCOA, your provider will evaluate safety risks (like muscle loss or gastrointestinal factors) and confirm you have received counseling on necessary lifestyle and nutritional changes.

• Step 2. Prior Authorization Submission 

  Your doctor submits a formal prior authorization (PA) request directly to the program's designated central processing center, confirming your qualifying metrics and clinical need. To find the PA form, Please follow this link https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge The form is located towarss the bottom of the page. But be aware, these applications are not accepted until the launch of the program, July 1st, 2026.

• Step 3 Backend Verification
  The central processing center reviews and adjudicates the PA request. Once approved, notification is pushed through the pharmacy network.

• Step 4 Pick up your perscription
   Once approved, the notification is pushed through the pharmacy network. You fill your prescription at your usual pharmacy for the flat $50 copay. Subsequent refills do not require a new approval unless your doctor switches you to a different covered GLP-1 drug.

If you have any questions regarding Medicare's new GLP-1 Bridge program, or had any other questions come up while reading, please dont hesitate to reach out to us! We are always happy to help. Just submit a form below, or Call us at 720-259-4777.